Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
about
Urinary Markers of Tubular Injury in Early Diabetic NephropathyProteomics for prediction of disease progression and response to therapy in diabetic kidney diseaseSerum amyloid a and risk of death and end-stage renal disease in diabetic kidney diseaseAre Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis.Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.Urinary Kidney Injury Molecules in Children with Iron-Deficiency AnemiaPrognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.The next generation of therapeutics for chronic kidney diseaseαKlotho and Chronic Kidney Disease.Urine liver fatty acid binding protein and chronic kidney disease progression.Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studiesUrinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.Diabetic kidney disease.Urinary NGAL-Positive Acute Kidney Injury and Poor Long-term Outcomes in Hospitalized Patients.Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.Early term effect of ureterorenoscopy (URS) on the Kidney: research measuring NGAL, KIM-1, FABP and CYS C levels in urine.Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.Silencing of SOCS-1 and SOCS-3 suppresses renal interstitial fibrosis by alleviating renal tubular damage in a rat model of hydronephrosis.Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.The Promise of Systems Biology for Diabetic Kidney Disease.Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
P2860
Q26746921-131DC0C3-B0AF-47C6-A9BC-4393CCBCB6BCQ26747131-1EACD9C6-9AD9-456F-9974-3D186AA79705Q33698768-2601B8AA-5163-4426-9C3B-136AE7E91AEAQ36210315-1FC3CC54-DBC8-4392-913B-BA6AD62010D2Q36250287-88D5C6F0-61B7-429D-B884-DAD8ADC28FD8Q36412804-58A8E55B-A759-4E6D-BB88-D5AB791A0C6AQ36770851-5B9132A5-9FB7-43EF-A00B-44E73B70C647Q36844894-227C0DE7-D3CF-4400-9F0F-9A1AE06AD915Q37051993-050F3058-EA70-4AF1-9D83-33172D994861Q37139796-905ED156-5A3F-4221-906C-2BE0098A7BE8Q38553932-5CBB5117-89E2-4C31-B701-AE04CB7C1739Q38845590-F30CDF33-668A-4B8D-9268-B964FEE86665Q39812781-1680D940-A9BC-44AD-91B1-4737FA6BA712Q40107790-D2B45845-EA5D-4087-A5D7-7250E02A4692Q40256539-C3923483-37A9-4A37-BF2A-84B7E8877D25Q40310730-F140F4B8-29A6-4BA7-A1FC-6CFFCF1CD570Q40715066-0BCFF1F6-8FA2-44BD-8C65-8373317A4998Q40823785-2FB15FFB-84F2-428F-80E2-39A62981C954Q42379412-4A2D2CEB-30E6-4010-A1C5-E4A09E58D2A3Q43721013-51F8809E-3053-48F8-9A0E-6204AB91FB5FQ46073252-75C5C708-9962-4312-9908-9763D6C7051DQ46117032-7A62E290-FB6C-46D0-BF49-4A380C964794Q47097398-6DBD8421-5A0B-4859-B262-B326273BB96AQ47613477-5E8DDE04-D52B-4E59-BAE4-0509CD3E064BQ47878548-62191F77-5020-4980-99F1-1CC85FF90AF3Q48101168-E17C65AC-712A-4A01-BA42-AA1DE987F4E9Q50020892-A2A2630C-D6A8-4321-91B7-4E239A33862DQ52341285-A6C1C05F-A969-4CA5-83A5-CA00E01F1C99Q58792811-AE762A50-3E9E-4216-BD5A-5E60C6C02833
P2860
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@ast
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@en
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@nl
type
label
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@ast
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@en
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@nl
prefLabel
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@ast
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@en
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@nl
P2093
P2860
P1433
P1476
Association of urinary KIM-1, ...... with type 2 diabetes mellitus
@en
P2093
Chi-Yuan Hsu
Chronic Kidney Disease Biomarkers Consortium Investigators
E Jennifer Weil
Gudeta D Fufaa
Harold I Feldman
Joseph V Bonventre
Kathleen D Liu
Paul L Kimmel
Robert G Nelson
P2860
P2888
P304
P356
10.1007/S00125-014-3389-3
P577
2014-10-15T00:00:00Z
P6179
1024523702